Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  McKesson Corporation    MCK

MCKESSON CORPORATION (MCK)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

McKesson Corporation : McKesson wins new two-year Veterans Affairs contract

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/12/2012 | 01:02am CEST

(Reuters) - Pharmaceutical wholesaler McKesson Corp on Wednesday said it was selected by the U.S. Department of Veterans Affairs to continue as the VA's prime pharmaceutical supplier for at least two more years.

News of the contract, which includes options for up to three two-year extensions, sent shares of McKesson up more than 4 percent in after hours trading.

The new agreement, valued by the VA at over $31.6 billion, calls for McKesson to supply all of the VA's more than 700 medical centers and outpatient clinics, as well as its seven consolidated mail outpatient pharmacies.

"Over the past eight years, McKesson has partnered with the VA to serve the healthcare needs of America's veterans," Paul Julian, the company's executive vice president and group president, said in a statement.

The VA, which estimated savings of about $3.26 billion through the life of the contract, said the new agreement goes into effect on May 10.

Shares of McKesson, which closed at $87.90 on the New York Stock Exchange, were trading at $91.89 after hours.

(Reporting By Deena Beasley, editing by M.D. Golan)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MCKESSON CORPORATION
05/21MCKESSON : How to Get Your Specialty Practice Ready for CAR-T Cell Therapies
PU
05/21MCKESSON CORPORATION : annual earnings release
05/17MCKESSON IDEASHARE : The Independent's Power to Perform
AQ
05/14MCKESSON : U.K. Best Practices for Your Independent Pharmacy on Better Patient C..
PU
05/11MCKESSON : NLRB Regional Director Issues Decision on McKesson V. Teamsters
AQ
05/09Opioid distributors say 'pill dumping' won't happen again
AQ
05/08Opioid Shipments to Small Towns Come Under Spotlight at Hearing
DJ
05/07House Energy and Commerce Committee - Hearing
AQ
05/07MCKESSON : Why Drug Spend Analytics Should Be at the Center of Your Hospital Pha..
PU
05/07MCKESSON : Six Ideas to Help Your Independent Pharmacy Provide Better Care
PU
More news
News from SeekingAlpha
05/16Mexico Sees Slim Chances For A New NAFTA Deal; The IEA Expects The Oil Price .. 
05/16WALL STREET BREAKFAST : Clock Ticks Down For New NAFTA 
05/16More states sue over opioid epidemic 
05/15Glenview added Express Scripts, exited Apple in Q1 
05/15Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update 
Financials ($)
Sales 2018 208 B
EBIT 2018 3 535 M
Net income 2018 1 076 M
Debt 2018 4 003 M
Yield 2018 0,85%
P/E ratio 2018 31,46
P/E ratio 2019 14,71
EV / Sales 2018 0,17x
EV / Sales 2019 0,16x
Capitalization 30 728 M
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MCK | US58155Q1031 | 4-Traders
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 176 $
Spread / Average Target 20%
EPS Revisions
Managers
NameTitle
John H. Hammergren Chairman, President & Chief Executive Officer
Britt Vitalone Chief Financial Officer & Executive Vice President
Kathleen D. McElligott Chief Technology & Information Officer, EVP
M. Christine Jacobs Independent Director
Marie L. Knowles Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION-3.18%30 728
CVS HEALTH CORPORATION-9.30%66 855
WALGREENS BOOTS ALLIANCE-9.13%65 440
EXPRESS SCRIPTS HOLDING CO0.00%42 887
AMERISOURCEBERGEN-7.68%19 138
CARDINAL HEALTH-12.96%17 098